Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy
Denise Bernhardt, Sophie Aufderstrasse, Laila König, et al.
Cancer Management and Research (2018) Vol. Volume 10, pp. 6563-6569
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Novel Biomarkers for Personalized Cancer Immunotherapy
Yoshitaro Shindo, Shoichi Hazama, Ryouichi Tsunedomi, et al.
Cancers (2019) Vol. 11, Iss. 9, pp. 1223-1223
Open Access | Times Cited: 44
Controlling Nutritional Status (CONUT) Score as a New Indicator of Prognosis in Patients With Hilar Cholangiocarcinoma Is Superior to NLR and PNI: A Single-Center Retrospective Study
Ankang Wang, Zhenxing He, Peng Cong, et al.
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 34
Inflammation scores as prognostic biomarkers in small cell lung cancer: a systematic review and meta-analysis
Anne Winther‐Larsen, Ninna Aggerholm‐Pedersen, Birgitte Sandfeld‐Paulsen
Systematic Reviews (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 34
Prognostic scores including peripheral blood-derived inflammatory indices in patients with advanced non-small-cell lung cancer treated with immune checkpoint inhibitors
Sara Elena Rebuzzi, Arsela Prelaj, Alex Friedlaender, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 179, pp. 103806-103806
Closed Access | Times Cited: 23
The Significance of Controlling Nutritional Status (CONUT) Score as a Novel Prognostic Parameter in Small Cell Lung Cancer
Ali Yılmaz, Salim Başol Tekin, Mehmet Bilici, et al.
Lung (2020) Vol. 198, Iss. 4, pp. 695-704
Closed Access | Times Cited: 38
High Systemic Immune-Inflammation Index (SII) Represents an Unfavorable Prognostic Factor for Small Cell Lung Cancer Treated with Etoposide and Platinum-Based Chemotherapy
Chunyan Wang, Jin Shi, Shanqi Xu, et al.
Lung (2020) Vol. 198, Iss. 2, pp. 405-414
Closed Access | Times Cited: 36
The combination of body composition conditions and systemic inflammatory markers has prognostic value for patients with gastric cancer treated with adjuvant chemoradiotherapy
Yi Li, Wenbo Wang, Lei Yang, et al.
Nutrition (2021) Vol. 93, pp. 111464-111464
Closed Access | Times Cited: 27
The clinicopathological and prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in small cell lung cancer: A meta-analysis
Yan Lu, Jinwen Jiang, Chaoxiang Ren
PLoS ONE (2020) Vol. 15, Iss. 4, pp. e0230979-e0230979
Open Access | Times Cited: 29
Correlation of Systemic Inflammation Parameters and Serum SLFN11 in Small Cell Lung Cancer—A Prospective Pilot Study
I. Simic, Azra Guzonjić, Jelena Kotur Stevuljević, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 976-976
Open Access | Times Cited: 3
Treatment patterns and survival outcomes for small-cell lung cancer patients – a Swedish single center cohort study
Salomon Tendler, Yiqiang Zhan, Andreas Pettersson, et al.
Acta Oncologica (2020) Vol. 59, Iss. 4, pp. 388-394
Open Access | Times Cited: 24
Immune Modulation in Lung Cancer: Current Concepts and Future Strategies
Lena Gaissmaier, Petros Christopoulos
Respiration (2020) Vol. 99, Iss. 11, pp. 903-929
Open Access | Times Cited: 23
<p>High systemic immune–inflammation index represents an unfavorable prognosis of malignant pleural mesothelioma</p>
Ming Ma, Nina Yu, Bing Wu
Cancer Management and Research (2019) Vol. Volume 11, pp. 3973-3979
Open Access | Times Cited: 22
High systemic immune-inflammation index is a predictor of poor prognosis in patients with nonsmall cell lung cancer and bone metastasis
Shanqi Xu, Shoubo Cao, Yan Yu
Journal of Cancer Research and Therapeutics (2021) Vol. 17, Iss. 7, pp. 1636-1642
Open Access | Times Cited: 16
Prognostic significance of novel inflammatory markers in extensive-stage small-cell lung cancer
Hatice Yılmaz, Özlem Yersal
Journal of Cancer Research and Therapeutics (2022) Vol. 18, Iss. 3, pp. 691-696
Open Access | Times Cited: 11
Lymphocyte-To-C-Reactive Protein Ratio Is A Potential New Prognostic Biomarker for Patients with Lung Cancer
Yuan He, Rui Gong, Kunwei Peng, et al.
Biomarkers in Medicine (2020) Vol. 14, Iss. 9, pp. 717-726
Closed Access | Times Cited: 16
Value of the Controlling Nutritional Status score in predicting the prognosis of patients with lung cancer: A multicenter, retrospective study
Xiaoyue Liu, Xi Zhang, Qi Zhang, et al.
Journal of Parenteral and Enteral Nutrition (2021) Vol. 46, Iss. 6, pp. 1343-1352
Closed Access | Times Cited: 15
Neutrophil-to-lymphocyte ratio can predict outcome in extensive-stage small cell lung cancer
Gordana Drpa, Maja Šutić, Jurica Baranašić, et al.
Radiology and Oncology (2020) Vol. 54, Iss. 4, pp. 437-446
Open Access | Times Cited: 15
The Influence of Systemic Inflammation Response Index on Survival Outcomes of Limited-Stage Small-Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy
Ahmet Küçük, Emine Elif Özkan, Sukran Eskici Oztep, et al.
Journal of Oncology (2020) Vol. 2020, pp. 1-8
Open Access | Times Cited: 13
The association between thrombocytosis and subtype of lung cancer: a systematic review and meta-analysis
Melissa Barlow, William Hamilton, Obioha C. Ukoumunne, et al.
Translational Cancer Research (2021) Vol. 10, Iss. 3, pp. 1249-1260
Open Access | Times Cited: 12
A novel analytical framework for risk stratification of real‐world data using machine learning: A small cell lung cancer study
Luca Marzano, Adam S. Darwich, Salomon Tendler, et al.
Clinical and Translational Science (2022) Vol. 15, Iss. 10, pp. 2437-2447
Open Access | Times Cited: 8
Effect of Pretreatment Platelet Parameters on Survival in Limited Disease Small Cell Lung Cancer
Abdullah Sakin, Nurgül Yaşar, Serdar Arıcı, et al.
Asian Pacific Journal of Cancer Prevention (2019) Vol. 20, Iss. 6, pp. 1879-1885
Open Access | Times Cited: 12
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Limited-Stage Small-Cell Lung Cancer: A Meta-Analysis
Shuang Zhang, Yansu Wang, Ying Cheng
Future Oncology (2023) Vol. 19, Iss. 18, pp. 1303-1314
Closed Access | Times Cited: 4
A Clinical Analysis of Anti-Programmed Death-Ligand 1 (PD-L1) Immune Checkpoint Inhibitor Treatments Combined with Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer
Ping‐Chih Hsu, Bing-Chen Wu, Chin‐Chou Wang, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 474-474
Open Access | Times Cited: 1
<p>Prognostic Significance Of Platelet-To-Lymphocyte Ratio (PLR) And Mean Platelet Volume (MPV) During Etoposide-Based First-Line Treatment In Small Cell Lung Cancer Patients</p>
Xia‐Bo Shen, Yong Wang, Benjie Shan, et al.
Cancer Management and Research (2019) Vol. Volume 11, pp. 8965-8975
Open Access | Times Cited: 11
The combination of pretreatment prognostic nutritional index and neuron‐specific enolase enhances prognosis predicting value of small cell lung cancer
Chunyan Wang, Jin Shi, Shanqi Xu, et al.
The Clinical Respiratory Journal (2020) Vol. 15, Iss. 3, pp. 264-271
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top